Please consider downloading the latest version of Internet Explorer
to experience this site as intended.
Tools Search Main Menu

Tag: Huntington’s Disease

Medical Center plays key role in new Huntington’s drug

Medical Center plays key role in new Huntington’s drug

April 5, 2017

Medical Center researchers were instrumental in the U.S. Food and Drug Administration’s recent approval of SD-809 (deutetrabenazine) to treat Huntington’s disease.

Continue Reading

Research to explore new therapies for Huntington’s disease

Research to explore new therapies for Huntington’s disease

October 12, 2016

A new grant anticipated to total more than $10.5 million over next five years will help Medical Center scientists develop a stem cell-based therapy that swaps sick brain cells for healthy ones.

Continue Reading

Swapping sick for healthy brain cells slows Huntington’s disease

Swapping sick for healthy brain cells slows Huntington’s disease

June 7, 2016

Medical Center researchers have successfully reduced the symptoms and slowed the progression of Huntington’s disease by replacing sick mouse glia cells with healthy human cells. The findings could ultimately point to a new method to treat the disease.

Continue Reading

Brain Cells Lost to Huntington’s Disease Regenerated

Brain Cells Lost to Huntington’s Disease Regenerated

June 6, 2013

Scientists used a modified virus to infect target cells in the brains of affected mice, and trigger the sustained over-expression of proteins which, in turn, activated the neighboring neural stem cells to produce neurons.

Continue Reading